Menopause Hormone Therapy (HRT) in Murfreesboro, TN

Bioidentical hormones in Murfreesboro: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Estradiol and micronized progesterone are both bioidentical: their structure matches the hormones the ovaries make. FDA-approved versions of both are sold by prescription at retail pharmacies.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. None of these is FDA-approved, and the FDA has not reviewed them for safety, effectiveness or quality before sale. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. When the National Academies reviewed them in 2020, the evidence was mostly low quality, such as anecdotes and patient reports.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in Tennessee decides what, if anything, fits, and the form. VevaMD does not offer pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

At 17.8 OB-GYNs per 100,000 residents (28 listed in the NPI registry), Murfreesboro sits near the national 17.8 and above Tennessee's 15.5; 45% of the cities VevaMD covers have a lower rate. With about 17,248 women aged 45 to 64 living in Murfreesboro, that is about 620 for each OB-GYN in the city, before counting any younger patients.

Supply stays thin beyond the city line: 42 OB-GYNs within 10 miles and 92 within 25, only 10.8 per 100,000 of the 849,206 people who live in that radius, under the US 17.8. None of this replaces your own OB-GYN or a menopause doctor you trust; VevaMD adds an online route, with a physician licensed in Tennessee reviewing your answers from home in Murfreesboro.

BHRT pellet clinics work differently: they place a hormone pellet under the skin in the office, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG's guidance is to prefer FDA-approved menopause hormone therapy to compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11